An MR1-specific nanobody capable of blocking MR1T cell activation. - Bates TA; Kulicke CA; Gurmessa SK; Kim SJ; Suresh S; Reyes-Weinstein JB; Hinchliff A; Burke JE; Lewinsohn DM; Tafesse FG (Journal of immunology (Baltimore, Md. : 1950), 2026)